# Efficacy of Ranibizumab Therapy With Aflibercept in Patients With Diabetic Macular Edema

> **NCT02646670** · PHASE4 · COMPLETED · sponsor: **Instituto de Olhos de Goiania** · enrollment: 20 (actual)

## Conditions studied

- Retinal Diseases

## Interventions

- **DRUG:** Ranibizumab
- **DRUG:** Aflibercept
- **DRUG:** Ranibizumab and Aflibercept
- **DRUG:** Aflibercept and ranibizumab

## Key facts

- **NCT ID:** NCT02646670
- **Lead sponsor:** Instituto de Olhos de Goiania
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07
- **Primary completion:** 2015-10
- **Final completion:** 2015-11
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2016-01-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02646670

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02646670, "Efficacy of Ranibizumab Therapy With Aflibercept in Patients With Diabetic Macular Edema". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02646670. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*